Cargando…
Apelin-13 in septic shock: effective in supporting hemodynamics in sheep but compromised by enzymatic breakdown in patients
Sepsis is a prevalent life-threatening condition related to a systemic infection, and with unresolved issues including refractory septic shock and organ failures. Endogenously released catecholamines are often inefficient to maintain blood pressure, and low reactivity to exogenous catecholamines wit...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611018/ https://www.ncbi.nlm.nih.gov/pubmed/34815457 http://dx.doi.org/10.1038/s41598-021-02087-4 |
_version_ | 1784603216958193664 |
---|---|
author | Coquerel, David Lamoureux, Julie Chagnon, Frédéric Trân, Kien Sage, Michael Fortin-Pellerin, Etienne Delile, Eugénie Sainsily, Xavier Fournier, Justin Dumont, Audrey-Ann Auger-Messier, Mannix Sarret, Philippe Marsault, Eric Praud, Jean-Paul Fülöp, Tamàs Lesur, Olivier |
author_facet | Coquerel, David Lamoureux, Julie Chagnon, Frédéric Trân, Kien Sage, Michael Fortin-Pellerin, Etienne Delile, Eugénie Sainsily, Xavier Fournier, Justin Dumont, Audrey-Ann Auger-Messier, Mannix Sarret, Philippe Marsault, Eric Praud, Jean-Paul Fülöp, Tamàs Lesur, Olivier |
author_sort | Coquerel, David |
collection | PubMed |
description | Sepsis is a prevalent life-threatening condition related to a systemic infection, and with unresolved issues including refractory septic shock and organ failures. Endogenously released catecholamines are often inefficient to maintain blood pressure, and low reactivity to exogenous catecholamines with risk of sympathetic overstimulation is well documented in septic shock. In this context, apelinergics are efficient and safe inotrope and vasoregulator in rodents. However, their utility in a larger animal model as well as the limitations with regards to the enzymatic breakdown during sepsis, need to be investigated. The therapeutic potential and degradation of apelinergics in sepsis were tested experimentally and in a cohort of patients. (1) 36 sheep with or without fecal peritonitis-induced septic shock (a large animal experimental design aimed to mimic the human septic shock paradigm) were evaluated for hemodynamic and renal responsiveness to incremental doses of two dominant apelinergics: apelin-13 (APLN-13) or Elabela (ELA), and (2) 52 subjects (33 patients with sepsis/septic shock and 19 healthy volunteers) were investigated for early levels of endogenous apelinergics in the blood, the related enzymatic degradation profile, and data regarding sepsis outcome. APLN-13 was the only one apelinergic which efficiently improved hemodynamics in both healthy and septic sheep. Endogenous apelinergic levels early rose, and specific enzymatic breakdown activities potentially threatened endogenous apelin system reactivity and negatively impacted the outcome in human sepsis. Short-term exogenous APLN-13 infusion is helpful in stabilizing cardiorenal functions in ovine septic shock; however, this ability might be impaired by specific enzymatic systems triggered during the early time course of human sepsis. Strategies to improve resistance of APLN-13 to degradation and/or to overcome sepsis-induced enzymatic breakdown environment should guide future works. |
format | Online Article Text |
id | pubmed-8611018 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-86110182021-11-24 Apelin-13 in septic shock: effective in supporting hemodynamics in sheep but compromised by enzymatic breakdown in patients Coquerel, David Lamoureux, Julie Chagnon, Frédéric Trân, Kien Sage, Michael Fortin-Pellerin, Etienne Delile, Eugénie Sainsily, Xavier Fournier, Justin Dumont, Audrey-Ann Auger-Messier, Mannix Sarret, Philippe Marsault, Eric Praud, Jean-Paul Fülöp, Tamàs Lesur, Olivier Sci Rep Article Sepsis is a prevalent life-threatening condition related to a systemic infection, and with unresolved issues including refractory septic shock and organ failures. Endogenously released catecholamines are often inefficient to maintain blood pressure, and low reactivity to exogenous catecholamines with risk of sympathetic overstimulation is well documented in septic shock. In this context, apelinergics are efficient and safe inotrope and vasoregulator in rodents. However, their utility in a larger animal model as well as the limitations with regards to the enzymatic breakdown during sepsis, need to be investigated. The therapeutic potential and degradation of apelinergics in sepsis were tested experimentally and in a cohort of patients. (1) 36 sheep with or without fecal peritonitis-induced septic shock (a large animal experimental design aimed to mimic the human septic shock paradigm) were evaluated for hemodynamic and renal responsiveness to incremental doses of two dominant apelinergics: apelin-13 (APLN-13) or Elabela (ELA), and (2) 52 subjects (33 patients with sepsis/septic shock and 19 healthy volunteers) were investigated for early levels of endogenous apelinergics in the blood, the related enzymatic degradation profile, and data regarding sepsis outcome. APLN-13 was the only one apelinergic which efficiently improved hemodynamics in both healthy and septic sheep. Endogenous apelinergic levels early rose, and specific enzymatic breakdown activities potentially threatened endogenous apelin system reactivity and negatively impacted the outcome in human sepsis. Short-term exogenous APLN-13 infusion is helpful in stabilizing cardiorenal functions in ovine septic shock; however, this ability might be impaired by specific enzymatic systems triggered during the early time course of human sepsis. Strategies to improve resistance of APLN-13 to degradation and/or to overcome sepsis-induced enzymatic breakdown environment should guide future works. Nature Publishing Group UK 2021-11-23 /pmc/articles/PMC8611018/ /pubmed/34815457 http://dx.doi.org/10.1038/s41598-021-02087-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Coquerel, David Lamoureux, Julie Chagnon, Frédéric Trân, Kien Sage, Michael Fortin-Pellerin, Etienne Delile, Eugénie Sainsily, Xavier Fournier, Justin Dumont, Audrey-Ann Auger-Messier, Mannix Sarret, Philippe Marsault, Eric Praud, Jean-Paul Fülöp, Tamàs Lesur, Olivier Apelin-13 in septic shock: effective in supporting hemodynamics in sheep but compromised by enzymatic breakdown in patients |
title | Apelin-13 in septic shock: effective in supporting hemodynamics in sheep but compromised by enzymatic breakdown in patients |
title_full | Apelin-13 in septic shock: effective in supporting hemodynamics in sheep but compromised by enzymatic breakdown in patients |
title_fullStr | Apelin-13 in septic shock: effective in supporting hemodynamics in sheep but compromised by enzymatic breakdown in patients |
title_full_unstemmed | Apelin-13 in septic shock: effective in supporting hemodynamics in sheep but compromised by enzymatic breakdown in patients |
title_short | Apelin-13 in septic shock: effective in supporting hemodynamics in sheep but compromised by enzymatic breakdown in patients |
title_sort | apelin-13 in septic shock: effective in supporting hemodynamics in sheep but compromised by enzymatic breakdown in patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611018/ https://www.ncbi.nlm.nih.gov/pubmed/34815457 http://dx.doi.org/10.1038/s41598-021-02087-4 |
work_keys_str_mv | AT coquereldavid apelin13insepticshockeffectiveinsupportinghemodynamicsinsheepbutcompromisedbyenzymaticbreakdowninpatients AT lamoureuxjulie apelin13insepticshockeffectiveinsupportinghemodynamicsinsheepbutcompromisedbyenzymaticbreakdowninpatients AT chagnonfrederic apelin13insepticshockeffectiveinsupportinghemodynamicsinsheepbutcompromisedbyenzymaticbreakdowninpatients AT trankien apelin13insepticshockeffectiveinsupportinghemodynamicsinsheepbutcompromisedbyenzymaticbreakdowninpatients AT sagemichael apelin13insepticshockeffectiveinsupportinghemodynamicsinsheepbutcompromisedbyenzymaticbreakdowninpatients AT fortinpellerinetienne apelin13insepticshockeffectiveinsupportinghemodynamicsinsheepbutcompromisedbyenzymaticbreakdowninpatients AT delileeugenie apelin13insepticshockeffectiveinsupportinghemodynamicsinsheepbutcompromisedbyenzymaticbreakdowninpatients AT sainsilyxavier apelin13insepticshockeffectiveinsupportinghemodynamicsinsheepbutcompromisedbyenzymaticbreakdowninpatients AT fournierjustin apelin13insepticshockeffectiveinsupportinghemodynamicsinsheepbutcompromisedbyenzymaticbreakdowninpatients AT dumontaudreyann apelin13insepticshockeffectiveinsupportinghemodynamicsinsheepbutcompromisedbyenzymaticbreakdowninpatients AT augermessiermannix apelin13insepticshockeffectiveinsupportinghemodynamicsinsheepbutcompromisedbyenzymaticbreakdowninpatients AT sarretphilippe apelin13insepticshockeffectiveinsupportinghemodynamicsinsheepbutcompromisedbyenzymaticbreakdowninpatients AT marsaulteric apelin13insepticshockeffectiveinsupportinghemodynamicsinsheepbutcompromisedbyenzymaticbreakdowninpatients AT praudjeanpaul apelin13insepticshockeffectiveinsupportinghemodynamicsinsheepbutcompromisedbyenzymaticbreakdowninpatients AT fuloptamas apelin13insepticshockeffectiveinsupportinghemodynamicsinsheepbutcompromisedbyenzymaticbreakdowninpatients AT lesurolivier apelin13insepticshockeffectiveinsupportinghemodynamicsinsheepbutcompromisedbyenzymaticbreakdowninpatients |